Global Stoma/Ostomy Care Market to Grow at a CAGR 6.43% Through 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Stoma/Ostomy Care Market Analysis by Type, by Surgery Type by End user, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The stoma/ostomy care market size is estimated to be USD 3.2 billion in 2021 and is expected to witness a CAGR of 6.43% during the forecast … [Read more…]

US Heart & Vascular Welcomes Mike Englehart as Chief Executive Officer

USHV’s Leadership Team Grows to Strengthen its Mission to Partner with Cardiovascular Physicians Focused on High Quality Care in Support of Long-Term Goals for National Footprint Expansion NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced today that Mike Englehart has joined the organization as … [Read more…]

Future of Healthcare Rests on Technology Innovation and Connected Systems, ISG Experts Say

Novant, Whoop, Baptist Health South Florida, Health Union, Alexion will discuss patient engagement, ecosystem collaboration at ISG TechXchange Healthcare & Life Sciences event STAMFORD, Conn.–(BUSINESS WIRE)–$III #DigitalMedicine–Digital innovations and new operating models shaping the future of healthcare will be the focus of the upcoming ISG TechXchange: Healthcare and Life Sciences event, hosted by Information Services … [Read more…]

Netsmart Announces Intent to Become a Qualified Health Information Network to Drive the Evolution of Interoperability

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#EHR—Netsmart, the developer of the industry-leading CareFabric® platform for human services, post-acute care providers and payers, today announced its intent to apply to join the Trusted Exchange Framework and Common Agreement (TEFCA) to become a Qualified Health Information Network (QHIN). By supporting TEFCA, Netsmart continues its decade-long advancement of interoperability strategies to … [Read more…]

ParkourSC to Present in Panelist Discussion at LogiPharma U.S.A. 2022

ParkourSC will speak alongside pharmaceutical supply chain experts at Merck, Bristol Myers Squibb and AeroSafe Global BOSTON–(BUSINESS WIRE)–ParkourSC, a leader in supply chain technology solutions, today announced its participation and exhibition at LogiPharma U.S.A., taking place on September 29 – 30, 2022 in Boston, Massachusetts. What: LogiPharma U.S.A. convenes the top minds in life sciences … [Read more…]

Penumbra and Asahi Intecc Partner With Goal of Introducing Indigo™ System Including Lightning™ Intelligent Aspiration to Japan

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot removal in peripheral arterial and venous systems, including for diseases such as acute limb ischemia, vein thrombosis and pulmonary embolism First and only computer-aided mechanical aspiration technology that can differentiate … [Read more…]

Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 International Cancer Immunotherapy Conference

PHILADELPHIA–(BUSINESS WIRE)–Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced a poster presentation at the 2022 International Cancer Immunotherapy Conference (CICON) in New York City, NY, from September 28 – October 1, 2022. At the meeting, Imvax will present preclinical data that further elucidate the foundational anti-tumor immunological mechanisms of its … [Read more…]

TAE Life Sciences Sponsored Study Details Results of Proton Boron Fusion Therapy Biological Effectiveness

FOOTHILL RANCH, Calif.–(BUSINESS WIRE)–TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the publication of a study in the September 22 issue of the Journal of Medical Physics that assessed whether alpha particles generated through the combination of boron target drugs and proton radiation would generate … [Read more…]

ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the … [Read more…]

Pfizer Declares Fourth-Quarter 2022 Dividend

Board of Directors approves quarterly cash dividend of $0.40 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 fourth-quarter 2022 dividend on the company’s common stock, payable December 5, 2022, to holders of the Common Stock of record at the close of business on November 4, … [Read more…]